hematide: Clinical Trials

5 trials of hematide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow hematide: new trials by email Literature Review of hematide trials Research Report on hematide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
Epoetin, Peginesatide - Chronic Kidney Disease, Anemia
Phase 3CompletedTakeda1842011-10-012016-09-20
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
peginesatide, Darbepoetin alfa - Chronic Renal Failure, Chronic Kidney Disease
Phase 3CompletedAffymax4932007-11-012013-02-12
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
peginesatide, Epoetin alfa or Epoetin beta - Chronic Renal Failure, Chronic Kidney Disease
Phase 3CompletedAffymax8232007-10-012013-03-08
Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
peginesatide, Darbepoetin alfa - Chronic Renal Failure, Chronic Kidney Disease
Phase 3CompletedAffymax4902007-10-012013-02-12
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
peginesatide, Epoetin Alfa - Chronic Renal Failure, Chronic Kidney Disease
Phase 3CompletedAffymax8032007-09-012013-02-12

Conditions studied

Anemia (5)  ·  Kidney Failure, Chronic (5)  ·  Renal Insufficiency, Chronic (5)

Sponsors

Affymax (4)  ·  Takeda (1)

Countries

United States (5)  ·  Bulgaria (2)  ·  Germany (2)  ·  Italy (2)  ·  Poland (2)  ·  Puerto Rico (2)  ·  Romania (2)  ·  United Kingdom (2)  ·  Czechia (1)  ·  France (1)  ·  Hungary (1)  ·  Spain (1)

Top investigators

Vice President, Clinical Development (4)

Results publications

PMID 23343061, PMID 23343062